Boehringer Ingelheim GmbH won approval in the US for its drug to treat a challenging form of lung cancer, offering a growth avenue for the privately-held German pharmaceuticals company.
www.bloomberg.com
#Top #German #Pharma #Boehringer #Wins #Approval #Cancer #Drug
Top German Pharma Boehringer Wins US Approval for Cancer Drug
